COMMUNIQUÉS West-GlobeNewswire

Hemispherx Announces Dutch Health Inspectorate Approval to Extend the Ampligen Pancreatic Cancer Early Access Program Until March 2020
28/02/2019
OCALA, Fla., Feb. 28, 2019 (GLOBE NEWSWIRE) -- (NYSE American: HEB) — Hemispherx Biopharma, Inc. (NYSE American: HEB), an immuno-pharma R&D and emerging commercial growth company focused on unmet medical needs in [...]
Chemesis in Colombia: The Place to Be for South American Cannabis, Plus Exclusive CEO Interview -- CFN Media
28/02/2019
SEATTLE, Feb. 28, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
Abpro and NJCTTQ Enter Into Partnership for Development of Multiple Novel Bispecific Antibodies
28/02/2019
Abpro eligible to receive up to $4 billion, including $60 million in near-term R&D funding, plus potential milestones and royalties Collaboration to result in multiple new immuno-oncology bispecific therapeutic [...]
CTD Holdings Announces Grant to U.S. Non-Profit Organization to Support Patient Participation in Informational Meetings with Regulators
28/02/2019
Support is part of CTD’s efforts to recognize Rare Disease Day 2019 ALACHUA, Fla., Feb. 28, 2019 (GLOBE NEWSWIRE) -- CTD Holdings, Inc. (OTCQB: CTDH), a clinical stage biotechnology company that develops cyclodextrin- [...]
Apellis Pharmaceuticals Announces Collaboration with SFJ Pharmaceuticals® for APL-2 in Hematologic Indications
28/02/2019
Apellis to receive up to $120 million in upfront and near-term milestone payments, with the potential for additional payments subject to mutual agreement Apellis retains exclusive worldwide commercial rights to APL-2 in [...]
On “Grindeks” results in 2018
28/02/2019
Turnover of Grindeks reaches 145.5 million euros in 2018 Today, on 28 February, the JSC “Grindeks” submitted the non-audited consolidated financial statements of 2018 to Nasdaq Riga. Non-audited financial results [...]
Loos, France, RLG Headquarter, February 28th 2019 : ISOVITAL - Radiopharma Logistics Group (RLG) ; AFAQ ISO 9001-2015 certification successfully renewed for the “organization of transport for radioactive and hazardous materials”.
28/02/2019
Following the Jan 2019 AFAQ audit, Isovital is pleased to announce that is AFAQ ISO 9001 V2015 was successfully renewed until Fev 2022, for the “organization of transport for radioactive and hazardous materials”. [...]
Loos, France, siège d'Isovital, 28 février 2019 : ISOVITAL - Radiopharma Logistics Group (RLG) ; renouvellement de la certification AFAQ 9001-2015 pour « l’organisation de transport de matières radioactives et dangereuses ».
28/02/2019
Suite à l’audit de janvier 2019, Isovital est heureux d’annoncer le renouvellement de sa certification AFAQ 9001-2015 pour « l’organisation de transport de matières radioactives et dangereuses » Philippe Sueur, [...]
Todos Medical Raises $1,350,500 In Funding and Finalizes Joint Venture Agreement with Amarantus Bioscience
28/02/2019
JV to focus on the development of Alzheimer’s blood diagnostic LymPro Test 2.0 REHOVOT, Israel and NEW YORK, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Todos Medical Ltd. (OTCQB: TOMDF), a clinical-stage in-vitro diagnostics [...]
Aura Announces Signing of Definitive Share Purchase Agreement to Acquire Licenced Medical Cannabis Distributor in Germany
28/02/2019
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION OR DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES TORONTO, Feb. 28, 2019 ( [...]
RECORDATI: BOARD APPROVES THE 2018 ACCOUNTS. SALES € 1,352.2 MILLION (+5.0%), EBITDA € 499.1 MILLION (+9.8%), OPERATING INCOME € 442.2 MILLION (+8.8%) AND NET INCOME € 312.4 MILLION (+8.2%). 2018 DIVIDEND € 0.92 (+8.2%)
28/02/2019
RECORDATI: BOARD APPROVES THE 2018 ACCOUNTS. SALES € 1,352.2 MILLION (+5.0%), EBITDA € 499.1 MILLION (+9.8%), OPERATING INCOME € 442.2 MILLION (+8.8%) AND NET INCOME € 312.4 MILLION (+8.2%). 2018 DIVIDEND € 0.92 (+8.2 [...]
Zealand Pharma announces registration of executive management and an update of the Articles of Association
28/02/2019
Company announcement – No. 02 / 2019 Zealand Pharma announces registration of executive management and an update of the Articles of Association Copenhagen, February 28, 2019 – Zealand Pharma A/S (“Zealand”) (NASDAQ: [...]
Editas Medicine Supports Global Movement to Raise Awareness on Rare Disease Day®
28/02/2019
CAMBRIDGE, Mass., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Editas Medicine, Inc. (Nasdaq: EDIT), a leading genome editing company, announced today the Company is joining forces with the nearly 30 million Americans living with [...]
SR Scales Announces New Pediatric Scales
28/02/2019
SR635i Design Provides Large Contoured Base with Integrated Scale and Cart TONAWANDA, N.Y., Feb. 28, 2019 (GLOBE NEWSWIRE) -- SR Instruments, a leading manufacturer of purpose-built scales for hospitals, medical clinics [...]
Predictive Technology Group Names Jay M. Moyes to Its Board of Directors
28/02/2019
30-year healthcare veteran brings considerable financial and governance expertise SALT LAKE CITY, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Predictive Technology Group, Inc. (OTC PINK: PRED), a leader in the use of data [...]
Albireo Recognizes Rare Disease Day and Highlights Urgent Need to Support Families Affected by Progressive Familial Intrahepatic Cholestasis (PFIC)
28/02/2019
Advances in research and efforts to build awareness of life-threatening, rare, pediatric liver disease offer new hope for patients and families BOSTON, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Albireo Pharma, Inc. (NASDAQ: [...]
Sarepta Therapeutics Announces Second Year of Route 79, The Duchenne Scholarship Program
28/02/2019
The Company will award up to 20 academic scholarships to individuals diagnosed with Duchenne muscular dystrophy CAMBRIDGE, Mass., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in [...]
Dr. William Chey Highlights Unmet Medical Need of Lactose Intolerance and Potential for Phase 3 Drug Candidate RP-G28 in Expert Call Hosted by Ritter Pharmaceuticals
28/02/2019
LOS ANGELES, Feb. 28, 2019 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (Nasdaq: RTTR) (“Ritter Pharmaceuticals” or the “Company”), a developer of innovative therapeutic products that modulate the gut microbiome to [...]
Terra Tech Enters into Agreement to Acquire Remainder of Interest in Blüm Reno Dispensary
28/02/2019
IRVINE, Calif., Feb. 28, 2019 (GLOBE NEWSWIRE) -- Terra Tech Corp. ( TRTC ) ("Terra Tech") or (the "Company"), a vertically integrated cannabis-focused agriculture company, today announced it has entered into an [...]

Pages